United States · FDA National Drug Code directory
Eligard
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62935-756_58cff066-4345-4624-8868-4c232a051a5d
- Product NDC
- 62935-756
- Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- Leuprolide acetate
- Labeler
- TOLMAR Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20231101
- Source listing expiry
- 20271231
Source-listed ingredients
- LEUPROLIDE ACETATE — 7.5 mg/.25mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (62935-756-80) / .25 mL in 1 SYRINGE · 62935-756-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →